COVID-19 in neuromyelitis optica spectrum disorder patients in Poland.
作者信息
Podlecka-Piętowska Aleksandra, Barć Krzysztof, Denisiuk Agata, Nojszewska Monika, Zakrzewska-Pniewska Beata
机构信息
Departament of Neurology, Medical University of Warsaw, Banacha 1a, 02-097 Warsaw, Poland.
Departament of Neurology, Medical University of Warsaw, Banacha 1a, 02-097 Warsaw, Poland.
出版信息
Mult Scler Relat Disord. 2022 Apr;60:103698. doi: 10.1016/j.msard.2022.103698. Epub 2022 Feb 19.
Abstract
摘要
相似文献
1
COVID-19 in neuromyelitis optica spectrum disorder patients in Poland.
Mult Scler Relat Disord. 2022 Apr;60:103698. doi: 10.1016/j.msard.2022.103698. Epub 2022 Feb 19.
2
Neuromyelitis optica spectrum disorder after presumed coronavirus (COVID-19) infection: A case report.
Mult Scler Relat Disord. 2020 Nov;46:102474. doi: 10.1016/j.msard.2020.102474. Epub 2020 Sep 1.
3
Multiple sclerosis, neuromyelitis optica spectrum disorder and COVID-19: A pandemic year in Czechia.
Mult Scler Relat Disord. 2021 Sep;54:103104. doi: 10.1016/j.msard.2021.103104. Epub 2021 Jun 24.
4
The impact of COVID-19 on patients with neuromyelitis optica spectrum disorder; a pilot study.
Mult Scler Relat Disord. 2020 Oct;45:102347. doi: 10.1016/j.msard.2020.102347. Epub 2020 Jun 30.
5
Clinical Characteristics of Patients With Neuromyelitis Optica Spectrum Disorders With Early Onset.
J Child Neurol. 2019 Aug;34(9):487-490. doi: 10.1177/0883073819842421. Epub 2019 Apr 23.
6
Cognitive impairment in neuromyelitis optica spectrum disorders: What do we know?
Mult Scler Relat Disord. 2017 Nov;18:225-229. doi: 10.1016/j.msard.2017.10.003. Epub 2017 Oct 6.
7
Mild COVID-19 infection despite chronic B cell depletion in a patient with aquaporin-4-positive neuromyelitis optica spectrum disorder.
Mult Scler Relat Disord. 2020 Sep;44:102199. doi: 10.1016/j.msard.2020.102199. Epub 2020 May 19.
8
Suspected bacterial meningomyelitis: The first presenting clinical feature of neuromyelitis optica spectrum disorder.
J Neuroimmunol. 2017 Aug 15;309:68-71. doi: 10.1016/j.jneuroim.2017.05.013. Epub 2017 May 22.
9
Review of Neuromyelitis Optica Spectrum Disorder with Pain-Depression Comorbidity.
Chin Med Sci J. 2021 Dec 31;36(4):316-322. doi: 10.24920/003859.
10
Longitudinally extensive optic neuritis in neuromyelitis optica spectrum disorder.
J Neurol Sci. 2014 Oct 15;345(1-2):209-12. doi: 10.1016/j.jns.2014.07.049. Epub 2014 Jul 28.
本文引用的文献
1
Clinical Features of COVID-19 on Patients With Neuromyelitis Optica Spectrum Disorders.
Neurol Neuroimmunol Neuroinflamm. 2021 Aug 26;8(6). doi: 10.1212/NXI.0000000000001060. Print 2021 Nov.
2
COVID-19 in Patients With Neuromyelitis Optica Spectrum Disorders and Myelin Oligodendrocyte Glycoprotein Antibody Disease in North America: From the COViMS Registry.
Neurol Neuroimmunol Neuroinflamm. 2021 Aug 24;8(5). doi: 10.1212/NXI.0000000000001057. Print 2021 Sep.
3
Rituximab and risk of COVID-19 infection and its severity in patients with MS and NMOSD.
BMC Neurol. 2021 May 1;21(1):183. doi: 10.1186/s12883-021-02218-4.
4
COVID-19 in multiple sclerosis and neuromyelitis optica spectrum disorder patients in Latin America: COVID-19 in MS and NMOSD patients in LATAM.
Mult Scler Relat Disord. 2021 Jun;51:102886. doi: 10.1016/j.msard.2021.102886. Epub 2021 Mar 7.
5
Recent progress in maintenance treatment of neuromyelitis optica spectrum disorder.
J Neurol. 2021 Dec;268(12):4522-4536. doi: 10.1007/s00415-020-10235-5. Epub 2020 Oct 3.
Zotero 插件